Categories AlphaGraphs, Earnings, Technology

ADI Earnings: All you need to know about Analog Devices’ Q2 results

Analog Devices, Inc. (NASDAQ: ADI) has reported a double-digit increase in second-quarter revenues and adjusted profit. The chipmaker also provided guidance for the third quarter of 2022.

Analog Devices Q2 2022 Earnings Infographic

Second-quarter earnings, excluding special items, climbed to $2.40 per share from $1.54 per share in the comparable period of 2021. On a reported basis, net income was $783.3 million or $1.49 per share, compared to $422.9 million or $1.14 per share last year.

Driving the earnings growth, total revenues increased 79% annually to $2.97 billion. All four operating segments registered strong growth and the Automotive and Consumer divisions performed exceptionally well.


Read management/analysts’ comments on quarterly reports


Shares of Analog Devices traded lower early Thursday after closing the previous session lower. ADI has lost about 10% since the beginning of 2022.

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Microsoft (MSFT) reports higher revenue and profit for Q3 2024

Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,

GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results

Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top